NCT07535021 The Effect of Mandala Art Therapy, Psychological Resilience, Coping With Cancer, Colorectal Cancer Surgery
| NCT ID | NCT07535021 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cumhuriyet University |
| Condition | Colorectal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2026-01-01 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the effects of mandala art therapy on psychological resilience and coping with cancer in patients undergoing colorectal cancer surgery. This study was conducted as a randomized controlled trial with a pre-test-post-test design, including intervention and control groups. The study will be conducted between January 2026 and December 2026 with patients undergoing colorectal cancer surgery. The G.power 3.1.9.7 program was used for sample size calculation. The sample size was determined as 28 individuals in each group, considering equal sample sizes in the experimental and control groups, a 95% confidence interval (type I error 5%), and statistical power of 80% (type II error 20%) with an effect size of d=0.50. However, considering a possible 20% data loss, 35 individuals will be included in each group, resulting in a total sample size of 70 individuals. Sample selection will be made using sequential sampling according to inclusion criteria. Patients will then be randomly assigned to the experimental group (A) and the control group (B) using block randomization (four-block). First, 15 blocks of four, such as AABB, ABAB, ABBA, BBAA, BABA, BAAB, etc., will be prepared by the researcher and statistician. Individuals will then be divided into two groups according to the prepared list; this process will be repeated continuously until the sample size is complete. Three data collection forms were used. SPSS 22.00 software package was used for data analysis. Skewness and kurtosis analyses were performed to determine the normality of the data distribution. Frequency (n) and percentage (%) distributions were calculated to determine the sociodemographic and clinical characteristics of the participants. Independent samples t-test was used to determine the mean differences between two independent groups, dependent samples t-test was used to compare pre- and post-intervention measurements, and repeated measures one-way analysis of variance (ANOVA) was used. Cohen's d effect size was calculated to evaluate the significance of the difference between groups in terms of the intervention. The statistical significance level was accepted as p\<0.05.
Eligibility Criteria
Inclusion Criteria: * To communicate, * Aged 18 or older, * Agreed to participate * Scheduled for colorectal cancer surgery. * No physical disability of the upper extremities, * no visual problems, * no history of psychotic drug use, * pain intensity and fatigue level ≤3 points according to VAS-10 before MST application, * will be hospitalized for 3 days postoperatively, Exclusion Criteria: * Over 74 years old, * has not completed mandala art therapy application, * is not compliant with the application, * has a history of previous psychiatric diagnosis.
Contact & Investigator
Melis BOZOGLU
STUDY DIRECTOR
İstanbul Atlas University
Frequently Asked Questions
Who can join the NCT07535021 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 74 Years, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07535021 currently recruiting?
Yes, NCT07535021 is actively recruiting participants. Contact the research team at yilmazpinar20@gmail.com for enrollment information.
Where is the NCT07535021 trial being conducted?
This trial is being conducted at Sivas, Turkey (Türkiye).
Who is sponsoring the NCT07535021 clinical trial?
NCT07535021 is sponsored by Cumhuriyet University. The principal investigator is Melis BOZOGLU at İstanbul Atlas University. The trial plans to enroll 70 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.